ISRG Stock Recent News

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Equity markets can move every which way from one day to the next. The more we extend our horizon, the more likely it is that stocks will provide juicy returns.

Intuitive Surgical's ISRG recent device recall for its latest robotic surgery system, da Vinci 5, has been categorized by the FDA as a Class 2 recall, a grade below the most serious Class I recalls.

AI-powered robotics are set to soar in 2025. Key players like NVDA, ISRG, TSLA and PATH lead transformation across healthcare, manufacturing and mobility sectors.

Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Shares of Intuitive Surgical ISRG have declined 16.5% in the past month, with the price currently trading around its 200-day moving average (200-DMA). The price corrected after touching its all-time high of $616 in January, followed by a retest of the psychological level of $600 in February.

I am bullish on Intuitive Surgical, Inc. due to da Vinci 5's advanced capabilities, reducing surgery complications and blood transfusions significantly compared to open surgeries. Intuitive Surgical's da Vinci 5 offers enhanced range of motion, realistic 3D imaging, and reduced operative time, improving surgical outcomes and patient comfort. Despite being overvalued, ISRG's technological advancements and high investor expectations position it well for growth in the minimally invasive surgery market.

In a roughly three-week span, Wall Street has reminded investors that stocks can, indeed, go down just as easily as they can power higher.

In times of market turmoil -- like now -- two ideas in particular stand out: the need to own some "safe" stocks, or those that can hold up under pressure, and the opportunity to buy stocks, after declines, for a great price.

The Nasdaq has been a surefire winner over the past two years, soaring in the double digits annually. Investors were optimistic about the potential for a lower interest rate environment ahead and the fact that such a backdrop could benefit high-growth companies.